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Background and Objectives: Within the same surgical procedure, a great variabil-
ity on achievement of clinical outcomes exists and may be associated to different
molecular factors related to tissue healing. The aim of the present study was to
assess the distribution of clinical success separately in regenerative therapy
(REG) and open flap debridement (OFD) to evaluate if factors related with
healing of epithelium, connective tissue and bone may be associated to the clini-
cal outcome within each surgical procedure.
Material and Methods: Sixteen patients underwent periodontal REG and nine
patients underwent OFD. Periodontal wound fluid was collected at baseline, 3–
5, 7, 14 and 21 d after surgery, and expression of wound healing proteins was
assessed. Pocket depth and clinical attachment level were taken at baseline and
at 6 mo of follow-up. Percentage pocket depth reduction and percentage clinical
attachment level gain were computed. Patients were regarded as better or worse
responders depending on their percentage pocket depth reduction or percentage
clinical attachment level gain.
Results: Higher percentage of better responders was observed in the REG group
(68.7%) compared to the OFD group (22.2%). At 21 d, no difference in the
profile of most of the proteins emerged, with two exceptions, both regarding
REG treatment. Bone morphogenetic protein-7 tended to increase in better
responders and to decrease in worse responders. Matrix metalloproteinase-1
increased in worse responders and remained substantially unchanged in better
responders.
Conclusion: Local expression of matrix metalloproteinase-1 and bone morpho-
genetic protein-7 during wound healing is associated with the clinical perfor-
mance of periodontal regenerative surgery. The use of local biomarkers offers
the potential for real-time assessment of the periodontal healing process.
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Research on periodontal regenerative
therapy (REG) focus on even more
minimally invasive surgical approaches
(1,2), on biomaterials as scaffolds for
blood clot stabilization and cellular
migration (3) and on modulation of
bioavailability of molecular factors
that can move the wound healing
towards a regenerative rather than a
reparative pattern (4). This last
strategy of intervention requires full
knowledge of timing and amount of
expression of cell signaling proteins
that guide the formation of new peri-
odontal ligament after regenerative
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surgery. Furthermore, it is important
to know the differences in timing and
amount of molecule between regenera-
tion and repair so as to intervene selec-
tively on these differentiation factors.
During wound healing, a significant
number of cell signaling protein mole-
cules (e.g., growth factors, chemoki-
nes or cytokines) and products of
cellular activity (enzymes, adhesion
molecules) are released in the extracel-
lular matrix subsequent to tissue
injury associated with periodontal sur-
gical procedures. At the epithelium
level, E-cadherin is an adhesion mole-
cule that plays a key role in maintain-
ing the structural integrity and
function of the epithelial barrier (5).
Its expression reduces during pocket
formation and in periodontal patients
compared to healthy patients (6).
Epithelial growth factor (EGF) is a
molecule displaying an important role
on the stimulation of proliferation
and differentiation of epithelium and
mesenchymal tissues and re-epithelia-
lization of wound after acute injury
(7). An increased expression of this
protein was found in periodontally
diseased patients compared to healthy
patients (8). In the connective tissue,
transforming growth factor beta 1
(TGF-b1), vascular endothelial
growth factor (VEGF), fibroblast
growth factor 2 (FGF-2), matrix met-
alloproteinase-1 (MMP-1) and tissue
inhibitor metalloproteinases (TIMP-1)
are cell signaling proteins that work
by orchestrating and stimulating
angiogenesis, granulation tissue for-
mation, connective tissue regeneration
and remodeling (9–11). MMP-1 also
plays a role in keratinocyte migration
and thus re-epithelialization (12), and
in osteoblastic differentiation (13).
Bone morphogenetic protein 7 (BMP-
7) and osteoprotegerin (OPG) play a
role in bone tissue formation, respec-
tively inducing osteoblast differentia-
tion, bone formation/mineralization
and inhibiting osteoclastogenesis with
the consequent bone resorption (14–
16). BMP-7 also demonstrated a sig-
nificant effect on cementoblasts and
resulted in a potent stimulator of
cementogenesis in vivo (14).
All these molecules are soluble and
may be detected within the gingival
crevicular fluid in healthy tissues and
in periodontal wound fluid (PWF) in
postoperative tissues during healing
phases. Information about cellular
activity, as well as tissue formation,
remodeling, destruction and inflam-
mation is provided by the analysis of
specific molecules (10,17–19). How-
ever, no information is available
about whether a particular expression
profile of molecules associated to
epithelium, connective tissue and bone
may be indicative (biomarker) of a
clinical outcome after REG and open
flap debridement (OFD).
These two surgical procedures are
proposed based on the anatomy of
periodontal defect with the expecta-
tion of different healing patterns (re-
generation and repair). However,
within the same surgical procedure a
great variability on achievement of
clinical outcomes exists and may be
associated to different molecular
factors related to tissue healing.
Aim of the present study was to
assess the distribution of clinical suc-
cess separately in REG and OFD to
evaluate if factors related with healing
of epithelium (E-cadherin, EGF), con-
nective tissue (TGF-b1, VEGF, FGF-
2, MMP-1 and TIMP-1) and bone
(BMP-7, OPG) may be associated to
the clinical outcome within each
surgical procedure.
Material and methods
In this prospective clinical observa-
tional study a total of 32 patients
were enrolled. Each participant was
informed about the study protocol
and provided a written Institutional
Review Board-approved informed
consent form. The study was per-
formed following the principles out-
lined in the Declaration of Helsinki
on experimentation involving human
subjects. All procedures and materials
in the present study were approved by
the ethical committees at the Univer-
sity of Milan (Italy) and at the
University of Michigan (USA).
Enrolled subjects either had an infrab-
ony periodontal defect needing treat-
ment with the REG group or a
horizontal periodontal defect (without
infrabony components) needing
treatment with OFD (OFD group).
Each patient represented the statistical
unit and only one defect was treated
for each subject. Enrolled patients
presented the following inclusion cri-
teria:
• age range: 25–80 years;
• non-smoking (former smokers
were included if they had not
smoked within 6 mo of the study
initiation);
• OFD group: presence of at least
one tooth with probing pocket
depth > 5 mm and clinical
attachment level ≥ 6 mm associ-
ated with an intrabony defect
≤ 3 mm;
• REG group: presence of at least
one tooth with probing pocket
depth > 5 mm and clinical
attachment level ≥ 6 mm associ-
ated with an intrabony defect of
> 3 mm;
• full mouth plaque (FMPS) and
bleeding (FMBS) scores 20% at
study baseline;
• teeth vital or properly treated with
root canal therapy;
• absence of inadequate restora-
tions.
Exclusion criteria were:
• patients chronically treated (i.e.,
2 wk or more) with any medica-
tion that affect periodontal status
(i.e., antibiotics or non-steroidal
anti-inflammatory drugs), with
clinically significant or unstable
organic diseases or compromised
healing potential (i.e., connective
tissue disorders or bone metabolic
diseases);
• pregnant women or lactating;
• patients affected by active infec-
tious diseases, immune-compro-
mised, or taking steroid
medications.
Gingival crevicular fluid or
periodontal wound fluid harvesting
and analysis
In each subject of both groups (REG,
OFD), gingival crevicular fluid was
collected by an expert operator from
the tooth with the target lesion before
surgical procedure, and PWF was
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collected from the same tooth after
surgery. Briefly, before fluid collec-
tion, the harvesting site was air-dried
and the supragingival plaque was
removed by means of a cotton pellet.
A methylcellulose paper strip (Peri-
opaper; ProFlow Inc., Amityville,
NY, USA) was inserted into the gin-
gival sulcus, for about 1 mm, until a
slight resistance was felt and was left
in place for 30 s. All samples were
subsequently kept on dry ice and
stored at 20°C until needed for
analysis as reported by Cooke et al.
(17). Gingival crevicular fluid was
sampled at day 0 (baseline) and PWF
was collected 3–5, 7, 14 and 21 d after
surgery (for the timeline see Fig. 1).
Before the biomarker analysis, Peri-
opaper strips (Oraflow, Smithtown,
NY) containing gingival crevicular
fluid and PWF were thawed at room
temperature and proteins were eluted
as previously described (20). Biomar-
ker expression was quantified using a
Quantibody custom human slide-
based array kit (RayBiotech, Inc.,
Norcross, GA, USA) for the presence
of different biomarkers simultaneously
(E-cadherin, EGF, TGF-b1, VEGF,
FGF-2, MMP-1, TIMP-1, BMP-7
and OPG) according to the manufac-
turer’s protocol (10). Briefly, each
slide contained known concentrations
of standards (pg/mL) for each cyto-
kine, used for making serial dilutions
to yield a six-point standard curve,
with sample diluent serving as the
negative control. Standards and
experimental samples were incubated
overnight at 4°C followed by washing
unbound materials. The detection
antibody was then bound to the anti-
gens within each well. Cy3 equivalent
dye-conjugated streptavidin was pipet-
ted into each well, which bound to
the detection antibody associated with
immune complexes. The slides were
incubated and the fluorescence inten-
sity detected using a laser scanner.
The resultant signals of the samples
were compared to the standard curve
for each of the cytokines to determine
the concentrations of each cytokine
within the samples. Data were
extracted and analyzed using Quanti-
body Array analysis software (Ray-
Biotech, Inc.).
Clinical and radiographic analysis
Standardized intraoral radiographs of
the defect were taken using a Rinn’s
attachment and a long cone parallel
technique at baseline and 6 mo after
periodontal surgery.
Intraoral photographs of the exper-
imental sites were taken during sur-
gery, at 1, 2, 3 and 24 wk.
Clinical measurements were taken
at baseline and 6 mo after surgery:
• FMPS and FMBS on four sites
per tooth of the whole mouth.
• Periodontal parameters on four
sites of each tooth treated: prob-
ing pocket depth, recession, clini-
cal attachment level (calculated as
the sum of the probing pocket
depth and recession).
All measurements were taken with
an UNC periodontal probe (Hu-
Friedy Manufacturing Company Inc.,
Chicago, IL, USA).
Surgical procedures
Immediately before surgery, all
patients underwent a careful hygiene
phase receiving professional oral
hygiene procedures and instructions.
After local anesthesia (mepivacaine
2% 1 : 100,000 epinephrine) (Scan-
donest, Septodont, France) in all sites
(OFD and REG) full-thickness flap
was incised and elevated. In REG
sites the simplified papilla preserva-
tion technique (SPPT) or modified
papilla preservation technique
(MPPT) were adopted (21,22). The
SPPF was performed whenever the
width of the interdental space was
2 mm or narrower, while the MPPT
was applied at interdental sites wider
than 2 mm. The intra-sulcular inter-
dental incision (SPPF or MPPT) was
extended to the buccal and lingual
aspects of the mesial and distal teeth
adjacent to the defect. In OFD sites,
a modified Widman flap was per-
formed (23).
In both groups, after flap elevation,
the granulation tissue was removed
and the roots were planed by means
of mini-curettes (Gracey; Hu-Friedy)
and power-driven instruments (Son-
icflex; Lux, Kavo, Charlotte, NC,
USA). Vertical releasing incisions
were performed when flap reflection
caused tension at the extremities of
the flap(s).
Infrabony defects (REG) were
covered with a non-resorbable tita-
nium-reinforced completely inert mem-
brane (dense polytetrafluoroethylene,
d-PTFE) (Cytoplast; Osteogenics
Biomedical, Lubbock, TX, USA) alone
with no bone substitutes, while in hori-
zontal defects regeneration procedures
were not attempted (OFD). Buccal and
lingual flaps were re-positioned at their
original level, without any coronal dis-
placement to avoid any additional ten-
sion in the healing area. REG sites
were closed for primary intention with
a single modified internal mattress
suture 5/0 (expand polytetrafluo-
roethylene, e-PTFE) (Gore-tex; WL
Fig. 1. Timeline of the study. BL, baseline; CM, clinical measurements (probing depth,
clinical attachment level, full mouth plaque and full mouth bleeding scores) and intraoral
radiographs; d, days; GCFc, gingival crevicular fluid collection; m, months; MR, mem-
brane removal; PSM, post-surgical clinical assessments of healing (membrane exposure,
necrosis, erythema, bleeding and suppuration of soft tissue) oral hygiene instruction and
polishing performed by means of a rubber cup; PWFc, periodontal wound fluid collection;
w, weeks.
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Gore & Associates, Flagstaff, AZ,
USA). OFD sites were closed with sin-
gle external horizontal mattress suture
4/0 e-PTFE (Gore-tex; WL Gore &
Associates). Vertical releasing incisions
were sutured with interrupted sutures.
Postoperative pain and edema were
controlled with ibuprofen (600 mg at
the beginning of the surgical proce-
dure and 6 h later). Subsequent doses
were taken only if necessary to con-
trol pain. Patients with ulcers, gastri-
tis and other contraindications to
non-steroidal anti-inflammatory drugs
received 500 mg acetaminophen. All
patients were instructed to apply
intermittently an ice bag on the oper-
ated area (20 min per hour for 24 h).
All patients were instructed to discon-
tinue tooth brushing and avoid
trauma at the surgical site for a per-
iod of time between 3 and 4 wk. A
60 s rinse with 0.12% chlorhexidine
digluconate was prescribed 3 times/d
for the first 3–4 wk.
Statistical analysis
The patients participating in this
study were grouped by treatment
administered (REG or OFD). The
clinical outcome was evaluated in
terms of percentage pocket depth
reduction (PDr%) and percentage
clinical attachment level gain (CALg
%) in the first 6 mo after surgery,
and subjects were classified into two
outcome groups: worse responders
(below the 50th centile of PDr% and
CALg% distribution) and better
responders (above the 50th centile).
The between treatments difference
was tested with Fisher’s exact test.
Protein values were log-trans-
formed (log{value+1}) to reduce the
skewness of their distribution. Protein
log values recorded at baseline and at
4, 7, 14 and 21 d after surgery were
fitted with a linear model for repeated
measurements, separately for each
treatment group, and possible differ-
ences between outcome groups at
baseline and in mean daily change
Table 1. Demographic data and basal
FMPS, FMBS, PD and CAL (OFD) of
subjects under study
REG
(n = 16)
Mean (SD)
OFD
(n = 9)
Mean (SD)
Gender
(no. female)
12 (75%) 4 (44%)
Age (years) 55.23  8.74 58.33  7.51
FMPS 5.5  2.0 6.2  4.2
FMBS 3.4  2.5 3.8  3.0
PD (mm) 8.1  1.9 5.6  0.7
CAL (mm) 9.8  3.0 6.3  2.1
CAL, clinical attachment level; FMBS, full
mouth bleeding score; FMPS, full mouth
plaque score; OFD, open flap debridement;
PD, pocket depth; REG, regenerative
therapy.
A C E
B D F
Fig. 2. Regenerative therapy site: (A) pre-surgical X-ray. After degranulation, (B) the infrabony defect was covered with e-PTFE mem-
brane (C, D); X-rays and photographs were taken 6 mo after surgery (E, F).
Table 2. Outcome of REG and OFD treatments in terms of PDr% and CALg% (worse
responders: < 50th centile, and better responders > 50th centile). Between treatments dif-
ference was tested with Fisher’s exact test
REG (n = 16) OFD (n = 9) Total p
PDr%
< 50th centile 10 (62.5%) 5 (55.6%) 15 1.000
> 50th centile 6 (37.5%) 4 (44.4%) 10
CALg%
< 50th centile 5 (31.25%) 7 (77.8%) 12 0.041
> 50th centile 11 (68.75%) 2 (22.2%) 13
CALg%, percentage clinical attachment level gain; OFD, open flap debridement; PDr%,
percentage pocket depth reduction; REG, regenerative therapy.
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between baseline and 21 d after sur-
gery were tested. Data were analyzed
with SAS PROC MIXED (SAS Insti-
tute, Inc. 2008, SAS/STAT 9.2
User’s Guide; SAS Institute, Inc.,
Cary, NC, USA).
Results
All patients (n = 16) of the REG
group completed the study. Two
patients of the OFD group did not
perform the surgery, and five patients
of the same group did not show at
all control appointments; as their
data were incomplete they were
excluded from the computation and
a total of nine patients of the OFD
group were included in the analysis.
Samples from 25 patients (16 females
and nine males) (nine OFD and 16
REG) were analyzed. Figure S1
shows the patient flowchart. Table 1
reports demographic and clinical data
of patients at baseline. No difference
in the FMPS and FMBS was found
between the two treatment groups.
No site in OFD and REG was bleed-
ing on probing at baseline. Unevent-
ful wound healing occurred at all
operated sites. At sites treated with
REG, no membrane exposure
occurred and all membranes were
removed at 5–6 wk of healing
(Fig. 2).
Table 2 reports the association
between outcome and therapy. As for
CALg%, the percentage of better
responders was higher in the REG
group (68.7%) than in the OFD
group (22.2%, p = 0.041).
Table 3a and 3b report mean pro-
tein level (log-scale) at baseline by
outcome groups for PDr% and CALg
%, respectively. Basal levels of all
proteins under study were not signifi-
cantly different between outcome
groups, with the only exception of
EGF, which was lower in outcome
groups PDr% < 50th (p = 0.046) and
CALg% (p = 0.048), and FGF-2,
which was higher in PDr% < 50th
(p = 0.049), all exceptions regarding
the OFD treatment.
Tables 4a and 4b report, sepa-
rately by outcome groups, the mean
daily change in protein level (log-
scale) from baseline to day 21 after
surgery for PDr% and CALg%,
respectively. Mean daily changes of
all proteins under study were not
significantly different between out-
come groups, with the only two
exceptions regarding REG treat-
ment. BMP-7 values appeared to
increase in subjects with PDr%
> 50th centile (b = +0.074) and to
decrease in subjects with PDr%
< 50th centile (b = 0.072), the dif-
ference between trends being statisti-
cally significant (p = 0.041)
(Fig. 3A). MMP-1 values appeared
to increase in subjects with CALg
< 50th centile (b = +0.216) and to
Table 3. Mean (standard error) protein concentration (log-scale) at baseline by (a) PDr
% and (b) CALg% outcome groups
(a)
Protein PDr%
REG OFD
Mean  SE p Mean  SE p
E-cadherin < 50th centile 0.454  0.232 0.899 0.417  0.417 0.407
> 50th centile 0.504  0.320 0.000  0.000
EGF < 50th centile 2.293  0.336 0.976 1.581  0.760 0.046*
> 50th centile 2.277  0.412 4.121  0.684
TGF-b1 < 50th centile 1.896  0.809 0.250 1.781  1.124 0.675
> 50th centile 3.522  1.117 1.128  0.888
VEGF < 50th centile 4.054  0.274 0.213 3.830  0.322 0.721
> 50th centile 3.418  0.435 4.001  0.322
FGF-2 < 50th centile 1.848  0.533 0.693 3.194  0.163 0.049*
> 50th centile 1.501  0.673 1.382  0.844
MMP-1 < 50th centile 4.218  1.084 0.496 4.433  1.446 0.530
> 50th centile 5.269  0.661 5.781  1.382
TIMP-1 < 50th centile 9.337  0.160 0.828 9.137  0.296 0.110
> 50th centile 9.391  0.173 9.781  0.117
BMP-7 < 50th centile 2.007  0.833 0.738 2.040  1.252 0.787
> 50th centile 1.556  0.984 1.498  1.498
OPG < 50th centile 1.494  0.467 0.815 1.485  0.670 0.553
> 50th centile 1.322  0.515 2.119  0.772
(b)
Protein CALg%
REG OFD
Mean  SE p Mean  SE p
E-cadherin < 50th centile 0.568  0.348 0.737 0.298  0.298 0.626
> 50th centile 0.430  0.223 0.000  0.000
EGF < 50th centile 2.618  0.294 0.395 2.040  0.630 0.048*
> 50th centile 2.137  0.340 5.052  0.591
TGF-b1 < 50th centile 1.034  1.034 0.141 1.383  0.821 0.795
> 50th centile 3.174  0.793 1.869  1.869
VEGF < 50th centile 4.069  0.442 0.497 3.839  3.117 0.596
> 50th centile 3.700  0.295 4.142  3.378
FGF-2 < 50th centile 2.464  0.689 0.227 2.773  0.477 0.140
> 50th centile 1.378  0.486 1.044  1.044
MMP-1 < 50th centile 2.909  1.612 0.110 5.496  1.215 0.410
> 50th centile 5.386  0.674 3.408  0.075
TIMP-1 < 50th centile 9.412  0.234 0.760 9.347  0.246 0.518
> 50th centile 9.332  0.138 9.685  0.250
BMP-7 < 50th centile 1.735  1.064 0.915 1.457  0.943 0.516
> 50th centile 1.884  0.795 2.997  2.997
OPG < 50th centile 1.667  0.762 0.653 1.871  0.551 0.715
> 50th centile 1.322  0.377 1.401  1.401
BMP-7, bone morphogenetic protein 7; CALg%, percentage clinical attachment level gain;
EGF, epidermal growth factor; FGF-2, fibroblast growth factor 2; MMP-1, matrix metal-
loproteinase-1; OFD, open flap debridement; OPG; PDr%, percentage pocket depth
reduction; REG, regenerative therapy; TGF-b1, transforming growth factor beta 1; TIMP-
1, tissue inhibitor metalloproteinase 1; VEGF, vascular endothelial growth factor.
p values refer to the difference in mean basal protein concentration between the outcome
groups. *: < 0.05.
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remain substantially unchanged in
subjects with CALg > 50th centile
(b = + 0.060), the difference between
trends being statistically significant
(p = 0.025) (Fig. 3b). Figure 4A
and 4B reports levels of BMP-7 and
MMP-1 respectively for PDr% and
CALg%.
Discussion
In the present study, the expression of
proteins related to epithelium, connec-
tive tissue and bone has been
observed in PWF during the first
3 wk after REG or OFD, with the
aim of detecting possible biological
indicators of clinical outcome at 6 mo
after surgery.
At baseline, no substantial difference
in the level of the evaluated proteins
emerged between better and worse
responders, for both probing depth
and clinical attachment level outcome,
and for both treatment groups.
Table 4. Mean daily change ( standard error) in protein concentration (log-scale) from baseline to day 21 after surgery by (a) PDr%
and (b) CALg% outcome groups
(a)
Protein PDr%
REG OFD
b  SE pb pdiff b  SE pb pdiff
E-cadherin < 50th centile 0.012  0.011 0.271 0.670 0.014  0.016 0.416 0.339
> 50th centile 0.005  0.014 0.740 0.011  0.018 0.565
EGF < 50th centile 0.035  0.028 0.231 0.759 0.043  0.032 0.229 0.222
> 50th centile 0.049  0.036 0.194 0.022  0.036 0.555
TGF- b1 < 50th centile 0.087  0.037 0.036* 0.989 0.007  0.052 0.889 0.388
> 50th centile 0.086  0.048 0.096 0.080  0.059 0.214
VEGF < 50th centile 0.044  0.016 0.019* 0.928 0.008  0.016 0.619 0.801
> 50th centile 0.042  0.021 0.073 0.014  0.017 0.441
FGF-2 < 50th centile 0.019  0.031 0.547 0.133 0.004  0.028 0.867 0.345
> 50th centile 0.062  0.041 0.145 0.037  0.031 0.268
MMP-1 < 50th centile 0.149  0.040 0.002** 0.125 0.078  0.043 0.115 0.560
> 50th centile 0.042  0.051 0.425 0.038  0.048 0.456
TIMP-1 < 50th centile 0.019  0.005 0.002** 0.918 0.015  0.012 0.268 0.592
> 50th centile 0.018  0.006 0.018* 0.004  0.014 0.756
BMP-7 < 50th centile 0.072  0.039 0.091 0.041* 0.002  0.060 0.962 0.852
> 50th centile 0.074  0.051 0.171 0.014  0.067 0.835
OPG < 50th centile 0.013  0.019 0.522 0.136 0.012  0.037 0.742 0.345
> 50th centile 0.064  0.025 0.025* 0.069  0.041 0.140
(b)
Protein CALg%
REG OFD
b  SE pb pdiff b  SE pb pdiff
E-cadherin < 50th centile 0.022  0.015 0.151 0.309 0.008  0.014 0.597 0.486
> 50th centile 0.003  0.010 0.722 0.014  0.027 0.607
EGF < 50th centile 0.023  0.039 0.568 0.602 0.029  0.028 0.328 0.274
> 50th centile 0.048  0.026 0.090 0.041  0.053 0.458
TGF- b1 < 50th centile 0.075  0.053 0.175 0.800 0.029  0.046 0.542 0.655
> 50th centile 0.092  0.035 0.021* 0.075  0.087 0.412
VEGF < 50th centile 0.047  0.023 0.065 0.843 0.009  0.013 0.526 0.749
> 50th centile 0.042  0.016 0.020* 0.018  0.025 0.487
FGF-2 < 50th centile 0.033  0.046 0.483 0.263 0.016  0.025 0.542 0.860
> 50th centile 0.031  0.031 0.327 0.006  0.047 0.895
MMP-1 < 50th centile 0.216  0.051 0.001** 0.025* 0.070  0.036 0.099 0.597
> 50th centile 0.060  0.034 0.101 0.026  0.069 0.709
TIMP-1 < 50th centile 0.020  0.007 0.014* 0.740 0.010  0.011 0.379 0.966
> 50th centile 0.017  0.005 0.003** 0.011  0.020 0.599
BMP-7 < 50th centile 0.084  0.062 0.196 0.215 0.014  0.048 0.777 0.431
> 50th centile 0.013  0.042 0.760 0.071  0.090 0.456
OPG < 50th centile 0.006  0.029 0.821 0.312 0.039  0.033 0.280 0.926
> 50th centile 0.043  0.019 0.043* 0.032  0.062 0.621
BMP-7, bone morphogenetic protein 7; CALg%, percentage clinical attachment level gain; EGF, epidermal growth factor; FGF-2, fibrob-
last growth factor 2; MMP-1, matrix metalloproteinase-1; OFD, open flap debridement; OPG; PDr%, percentage pocket depth reduction;
REG, regenerative therapy; TGF-b1, transforming growth factor beta 1; TIMP-1, tissue inhibitor metalloproteinase 1; VEGF, vascular
endothelial growth factor.p values refer to mean daily change in each outcome group (pb) and to the difference in mean daily change
between the outcome groups (pdiff). *: < 0.05, **: < 0.01.
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In the period of 3 wk after surgery,
no important difference in the profile
of most of the evaluated proteins
emerged, with two noteworthy excep-
tions (both regarding REG treat-
ment). BMP-7 values tend to increase
in better responders and decrease in
worse responders. MMP-1 values
increase in worse responders and
remain substantially unchanged in
better responders.
Within the pool of molecules that
were considered, MMP-1 and BMP-7
resulted in the most accurate markers
to predict the favorable clinical out-
come of periodontal regeneration.
However, the expression of these pro-
teins was not indicative of the clinical
outcome of OFD surgeries. The clini-
cal scenarios (REG and OFD)
selected for this study represent two
different healing models. It has been
histologically demonstrated that the
regeneration of periodontal ligament
may occur within infrabony defects
covered with a space-maintaining bar-
rier (24). In OFD sites, where blood
clot is not protected, wound healing
occurs through a repair mechanism
and formation of a long junctional
epithelium (25). It could be hypothe-
sized that MMP-1 and BMP-7 are
biomarkers specific for periodontal
tissue regeneration, while they do not
seem indicators of the reparative pro-
cess.
MMP-1 is a collagenase responsible
for collagen type I degradation and
extracellular matrix turnover (11).
This protein plays an important role
in the pathogenesis of periodontal dis-
ease, and reduction of MMP-1 expres-
sion has been associated to beneficial
effects of periodontal non-surgical
therapy (26). During the normal
wound healing process, levels of this
protein decrease thus opening the pro-
liferative phase and permitting the tis-
sue regeneration (27,28). The
predictive role of this metallopro-
teinase in periodontal tissue regenera-
tion has not been investigated yet in
clinical study. Future studies would
be designed to evaluate further the
role of MMP-1 during the regenera-
tive healing of the periodontal com-
plex and to investigate how the
modulation of this protein during
Fig. 3. (A) Time profiles of BMP-7 log values in regenerative therapy treatment by PDr%
outcome groups: observed values and fitted lines. (B) Time profiles of MMP-1 log values
in regenerative therapy treatment by CALg% outcome groups: observed values and fitted
lines. BMP-7, bone morphogenetic protein 7; CALg%, percentage clinical attachment level
gain; MMP-1, matrix metalloproteinase; PDr%, percentage pocket depth reduction.
Fig. 4. (A) Time profiles of BMP-7 level in REG and OFD treatments by percentage
pocket depth reduction outcome groups. (B) Time profiles of MMP-1 level in REG and
OFD treatments by percentage clinical attachment level gain outcome groups. BMP-7,
bone morphogenetic protein 7; MMP-1, matrix metalloproteinase; OFD, open flap
debridement; REG, regenerative therapy.
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wound healing may favorably modify
the outcome of REG. BMP-7 is a
growth factor involved in osteogenesis
and cementogenesis (14,15). An ani-
mal study reported that BMP-7
applied in periodontal defects
improves periodontal wound healing
(15). A further study reported that
expression of BMP-7 in fracture heal-
ing peaks between 14 and 21 d in
mouse (29).
In the present study, the decrease
levels of MMP-1 3 wk after REG in
better responders may indicate the
transition to the connective tissue
regenerative phase of granulation tis-
sue within the chamber under the
membrane. The increased expression
of BMP-7 may indicate the improved
bone, periodontal ligament and
cementum formation in better than in
worse responders.
A higher percentage of better
responders, but only as far as CALg
% is concerned, was observed in the
REG group (68.7%) compared to the
OFD group (22.2%). Similarly,
molecular expression pattern resulted
in differences between REG and
OFD. After REG, healing activity
revealed a significant upward trend of
EGF, VEGF, MMP-1 and TIMP-1
and a downward trend of TGF-b1
and OPG. Otherwise, in sites treated
with the modified Widman flap only
OPG was significantly decreased.
These data indicate that within the
healing space under the membrane
that provided a stable chamber for a
blood clot, the granulation tissue for-
mation, and connective tissue model-
ing and maturation lasted for 3 wk
and was sustained by these proteins.
Otherwise, in OFD sites a coordi-
nated and time-dependent expression
pattern of the analyzed molecules was
not observed.
When this observational study was
planned, neither the expected effect
size nor the required size of the
study was determined. Nonetheless,
the two surgical approaches were
found to differ in pocket depth
reduction: patients classified as better
responders were 78% among those
who underwent OFD vs. 31% among
those who underwent REG. Under
the usual 0.05 risk of type I, the
current size of this study has a 0.80
power to detect a 62% difference in
the percentage of therapeutic success,
and a difference in mean protein con-
centration at baseline (or in mean
daily change), ranging from 1.6 SD
(success in PDr% in the REG group)
to 2.6 SD (success in CALg% in the
OFD group).
Owing to the limited number of sub-
jects under study, the anatomical con-
formation of the regenerated defects
was not compared; for the same reason
the comparative analysis of the expres-
sion profile of each biomarker in the
REG and OFD sites that presented
similar clinical behavior (in terms of
CALg% and PDr%) could not be per-
formed. Thus, further studies with lar-
ger populations and that investigate
further factors and timepoints need to
be designed. It would be interesting to
investigate how defect morphology (re-
maining bony walls, infrabony compo-
nent and radiographic angle) and
pocket depth at baseline affect protein
expression during healing and to have
more complete information on molec-
ular activity during periodontal repar-
ative and regenerative processes.
Molecules play a fundamental role in
the complex evolving scenery of peri-
odontal wound healing and determine
the clinical outcome. When the regen-
erative biomarker profile will be fully
established, studies aimed to modulate
to the expression profile of biomarkers
to guide the tissue regeneration and
improve clinical outcomes can be
designed more accurately.
Acknowledgements
The Authors thank James Sugai, Dr.
Elena Canciani, Dr. Rachele Ron-
cucci and Dr. Ivan Cortinovis for the
technical support. This study was
founded in part by the University of
Michigan Najjar Endowed Professor-
ship to WVG, and in part by Univer-
sity of Milan. The authors declare
that they have no conflict of interests.
Supporting Information
Additional Supporting Information
may be found in the online version of
this article:
Figure S1 Patient flowchart illus-
trating patient enrollment, distribu-
tion and completion.
References
1. Trombelli L, Farina R, Franceschetti G,
Calura G. Single-flap approach with buc-
cal access in periodontal reconstructive
procedures. J Periodontol 2009;80:
353–360.
2. Cortellini P, Tonetti MS. Improved
wound stability with a modified mini-
mally invasive surgical technique in the
regenerative treatment of isolated inter-
dental intrabony defects. J Clin Periodon-
tol 2009;36:157–163.
3. Rasperini G, Pilipchuk SP, Flanagan CL
et al. 3D-printed bioresorbable scaffold
for periodontal repair. J Dent Res
2015;94:153S–157S.
4. Nevins M, Kao RT, McGuire MK et al.
Platelet-derived growth factor promotes
periodontal regeneration in localized oss-
eous defects: 36-month extension results
from a randomized, controlled, double-
masked clinical trial. J Periodontol
2013;84:456–464.
5. Fujita T, Hayashida K, Shiba H et al.
The expressions of claudin-1 and E-cad-
herin in junctional epithelium. J Peri-
odontal Res 2010;45:579–582.
6. Nagarakanti S, Ramya S, Babu P, Arun
KV, Sudarsan S. Differential expression
of E-cadherin and cytokeratin 19 and net
proliferative rate of gingival ker-
atinocytes in oral epithelium in periodon-
tal health and disease. J Periodontol
2007;78:2197–2202.
7. Barrientos S, Stojadinovic O, Golinko
MS, Brem H, Tomic-Canic M. Growth
factors and cytokines in wound healing.
Wound Repair Regen 2008;16:585–601.
8. Sakai A, Ohshima M, Sugano N, Otsuka
K, Ito K. Profiling the cytokines in gingival
crevicular fluid using a cytokine antibody
array. J Periodontol 2006;77:856–864.
9. Barrientos S, Brem H, Stojadinovic O,
Tomic-Canic M. Clinical application of
growth factors and cytokines in wound
healing. Wound Repair Regen
2014;22:569–578.
10. Morelli T, Neiva R, Nevins ML et al.
Angiogenic biomarkers and healing of
living cellular constructs. J Dent Res
2011;90:456–462.
11. Page-McCaw A, Ewald AJ, Werb Z.
Matrix metalloproteinases and the regu-
lation of tissue remodelling. Nat Rev Mol
Cell Biol 2007;8:221–233.
12. Varani J, Perone P, Deming MO et al.
Impaired keratinocyte function on matrix
metalloproteinase-1 (MMP-1) damaged
collagen. Arch Dermatol Res
2009;301:497–506.
Biomarkers in periodontal regeneration 395
13. Hayami T, Kapila YL, Kapila S.
MMP-1 (collagenase-1) and MMP-13
(collagenase-3) differentially regulate
markers of osteoblastic differentiation in
osteogenic cells. Matrix Biol 2008;27:
682–692.
14. Hakki SS, Foster BL, Nagatomo KJ
et al. Bone morphogenetic protein-7
enhances cementoblast function in
vitro. J Periodontol 2010;81:1663–1674.
15. Jin QM, Anusaksathien O, Webb SA,
Rutherford RB, Giannobile WV. Gene
therapy of bone morphogenetic protein
for periodontal tissue engineering. J Peri-
odontol 2003;74:202–213.
16. Jin Q, Cirelli JA, Park CH et al.
RANKL inhibition through osteoprote-
gerin blocks bone loss in experimental
periodontitis. J Periodontol 2007;78:
1300–1308.
17. Cooke JW, Sarment DP, Whitesman LA
et al. Effect of rhPDGF-BB delivery on
mediators of periodontal wound repair.
Tissue Eng 2006;12:1441–1450.
18. Kuru L, Griffiths S, Petrie A, Olsen I.
Changes in transforming growth factor-
beta1 in gingival crevicular fluid follow-
ing periodontal surgery. J Clin Periodon-
tol 2004;31:527–533.
19. Kuru L, Kirby AC, Griffiths GS, Petrie
A, Olsen I. Changes in soluble adhesion
molecules in gingival crevicular fluid fol-
lowing periodontal surgery. J Periodontol
2005;76:526–533.
20. Giannobile WV, Lynch SE, Denmark
RG, Paquette DW, Fiorellini JP, Williams
RC. Crevicular fluid osteocalcin and
pyridinoline cross-linked carboxyterminal
telopeptide of type I collagen (ICTP) as
markers of rapid bone turnover in peri-
odontitis. A pilot study in beagle dogs. J
Clin Periodontol 1995;22:903–910.
21. Cortellini P, Prato GP, Tonetti MS. The
simplified papilla preservation flap. A
novel surgical approach for the manage-
ment of soft tissues in regenerative proce-
dures. Int J Periodontics Restorative Dent
1999;19:589–599.
22. Cortellini P, Prato GP, Tonetti MS. The
modified papilla preservation technique.
A new surgical approach for interproxi-
mal regenerative procedures. J Periodon-
tol 1995;66:261–266.
23. Ramfjord SP, Nissle RR. The modified
Widman flap. J Periodontol 1974;45:601–
607.
24. Nyman S, Lindhe J, Karring T, Rylander
H. New attachment following surgical
treatment of human periodontal disease.
J Clin Periodontol 1982;9:
290–296.
25. Caton J, Nyman S. Histometric evalua-
tion of periodontal surgery. I. The modi-
fied Widman flap procedure. J Clin
Periodontol 1980;7:212–223.
26. Goncalves PF, Huang H, McAninley S
et al. Periodontal treatment reduces
matrix metalloproteinase levels in local-
ized aggressive periodontitis. J Periodon-
tol 2013;84:1801–1808.
27. T€uter G, Kurtis B, Serdar M. Effects of
phase I periodontal treatment on gingival
crevicular fluid levels of matrix metallopro-
teinase-1 and tissue inhibitor of metallopro-
teinase-1. J Periodontol 2002;73:487–493.
28. Muller M, Trocme C, Lardy B, Morel F,
Halimi S, Benhamou PY. Matrix metal-
loproteinases and diabetic foot ulcers:
the ratio of MMP-1 to TIMP-1 is a pre-
dictor of wound healing. Diabet Med
2008;25:419–426.
29. Cho TJ, Gerstenfeld LC, Einhorn TA.
Differential temporal expression of mem-
bers of the transforming growth factor
beta superfamily during murine fracture
healing. J Bone Miner Res 2002;17:513–
520.
396 Pellegrini et al.
